Todos Announces Notice of Allowance From USPTO for Patent
Claims covering inhibition of 3CL protease, inflammation and autophagy underscore Dr. Dorit Arad’s lifelong work NEW YORK, NY, ALPHARETTA, GA...
Source: globenewswire.com
Stay updated with breaking news from Dorit Arad. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Claims covering inhibition of 3CL protease, inflammation and autophagy underscore Dr. Dorit Arad’s lifelong work NEW YORK, NY, ALPHARETTA, GA...
Press release content from NewMediaWire. The AP news staff was not involved in its creation.
Todos Medical Ltd. (OTCQB:TOMDF) said its majority-owned subsidiary 3CL Pharma Ltd has finished plans for a proposed safety and efficacy clinical trial for...
Press release content from NewMediaWire. The AP news staff was not involved in its creation.
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires